Clinical Trial

Evaluation of a Decision Analysis Model in the DASH-Osteo Decision Aid.

Study acronym: DASH-Osteo
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated August 13, 2025 (before its estimated December 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
Fragility fractures, often caused by low bone mineral density, are a major health concern for postmenopausal women. One way to prevent these fractures is by taking medication, but deciding whether to start treatment can be difficult due to potential risks and side effects. This study will test a web-based tool designed to help women make informed decisions about fracture prevention treatment. The tool provides information about the benefits and risks of treatment. Some women in the study will also receive additional support through a decision analysis report, which helps weigh different factors when making a choice. The study will examine whether using this tool improves decision-making, increases confidence in making a choice, and enhances satisfaction with the decision. It will also explore what factors influence women's decisions and at what level of risk they choose to start treatment. By understanding how decision aids impact choices, researchers aim to improve the way healthcare providers support patients in making informed decisions about their health.
Trial Details
NCT Number NCT07120854
Lead Sponsor Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Collaborators: Institut Catala de Salut, Servicio Madrileño de Salud, Madrid, Spain, Fondo de Investigacion Sanitaria
Conditions Osteoporosis, Postmenopausal, Osteoporotic Fractures, Diphosphonates, Fracture Risk Assessment
Enrollment 114 participants
Start Date 2025-04-03
Primary Completion 2025-12-20 (estimated)
Study Completion 2026-02-25 (estimated)
Updated on ClinicalTrials.gov 2025-08-13